FDA on Monday issued a much-anticipated, and controversial, approval to aducanumab, a Biogen drug to treat Alzheimer's disease—despite significant uncertainty as to how well the drug works. As Advisory Board's Nick Hula writes, providers must ask themselves three big questions to understand whether they're prepared to leverage aducanumab effectively.
Hospitalization rates for Covid-19 among adolescents ages 12 to 17 rose between March 1 and April 24 after declining in January and February—and many of the hospitalized teens were "perfectly healthy" before they contracted the coronavirus.
For more than 20 years, a woman experienced a range of symptoms in her right ear—including vertigo, tinnitus, hearing loss, and more—but doctors couldn't figure out what was wrong. Then, the woman's dental hygienist made a discovery on a CT scan, Lisa Sanders reports for the New York Times Magazine.
Kentucky Attorney General Daniel Cameron on Wednesday filed a lawsuit against CVS Health, alleging the pharmacy chain played a role in "fueling the [opioid] crisis" by sending millions of doses of prescription painkillers to the state, in today's bite-sized hospital and health industry news from Florida, Kentucky, and Texas.